Elite Pharmaceuticals Inc (ELTP)
0.1325
0.00 (0.00%)
USD |
OTCM |
Apr 26, 15:59
Elite Pharmaceuticals Gross Profit Margin (Quarterly): 45.31% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 45.31% |
| September 30, 2023 | 45.54% |
| June 30, 2023 | 52.90% |
| March 31, 2023 | 39.82% |
| December 31, 2022 | 53.18% |
| September 30, 2022 | 44.54% |
| June 30, 2022 | 52.10% |
| March 31, 2022 | 44.51% |
| December 31, 2021 | 44.77% |
| September 30, 2021 | 44.03% |
| June 30, 2021 | 50.36% |
| March 31, 2021 | 42.45% |
| December 31, 2020 | 56.29% |
| September 30, 2020 | 48.94% |
| June 30, 2020 | 39.48% |
| March 31, 2020 | 49.73% |
| December 31, 2019 | 57.20% |
| September 30, 2019 | 28.67% |
| June 30, 2019 | 38.67% |
| March 31, 2019 | 39.66% |
| December 31, 2018 | 34.26% |
| September 30, 2018 | 60.20% |
| June 30, 2018 | 27.28% |
| March 31, 2018 | 71.11% |
| December 31, 2017 | 44.00% |
| Date | Value |
|---|---|
| September 30, 2017 | 62.12% |
| June 30, 2017 | 40.39% |
| March 31, 2017 | 89.45% |
| December 31, 2016 | 25.91% |
| September 30, 2016 | 31.09% |
| June 30, 2016 | 34.35% |
| March 31, 2016 | 80.04% |
| December 31, 2015 | 61.91% |
| September 30, 2015 | 51.99% |
| June 30, 2015 | 44.66% |
| March 31, 2015 | 26.78% |
| December 31, 2014 | 48.66% |
| September 30, 2014 | 45.74% |
| June 30, 2014 | 37.29% |
| March 31, 2014 | -1.78% |
| December 31, 2013 | 41.26% |
| September 30, 2013 | 46.79% |
| June 30, 2013 | 19.77% |
| March 31, 2013 | 26.82% |
| December 31, 2012 | 60.04% |
| September 30, 2012 | 24.41% |
| June 30, 2012 | 21.47% |
| March 31, 2012 | 45.33% |
| December 31, 2011 | 69.29% |
| September 30, 2011 | 72.16% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
28.67%
Minimum
Sep 2019
57.20%
Maximum
Dec 2019
46.24%
Average
45.31%
Median
Dec 2023
Gross Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 43.02% |
| Return on Assets | 27.24% |
| Return on Invested Capital | 34.76% |
| Profit Margin (Quarterly) | 4.55% |
| Operating Margin (Quarterly) | 22.73% |
| Return on Net Operating Assets | 33.43% |